Alpha Tau Medical DRTS
NASDAQ DRTS
$14.91 -0.28 (-1.84%)
At close: Sep 30, 2026 · 4:00 PM EDT

Alpha Tau Medical (DRTS) Current Deferred Revenue (2026)

Updated

Alpha Tau Medical (DRTS) recorded Current Deferred Revenue of $18.88 million in the quarter ended Jun 30, 2026.

Analysis

Alpha Tau Medical (DRTS) Current Deferred Revenue (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn
10 Alpha Tau Medical 1.34 Bn 1.23 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.88 Mn
API Access

Alpha Tau Medical Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=DRTS&period=max&api_key=YOUR_API_KEY